Aspire Biopharma Holdings (ASBP) Other Non-Current Assets (2022)
Aspire Biopharma Holdings' (ASBP) quarterly Other Non-Current Assets came in at $80170.0 in Q4 2022, down 65.27% on a QoQ basis from $230848.0 in Q3 2022.
Aspire Biopharma Holdings (ASBP) Other Non-Current Assets (2022) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 1 years of Other Non-Current Assets data on file, last reported at $80170.0 in Q4 2022.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $80170.0 in Q4 2022; TTM through Dec 2022 was $80170.0, a N/A change from a year earlier, with the FY2022 full-year figure at $80170.0, changed N/A from the prior year.
- Other Non-Current Assets for Q4 2022 stood at $80170.0, down from $230848.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for ASBP reached as high as $530459.0 in Q1 2022 and fell as low as $80170.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 80,170.00 |
| Sep 30, 2022 | 230,848.00 |
| Jun 30, 2022 | 381,472.00 |
| Mar 31, 2022 | 530,459.00 |